| Yoon K Cho, MD | |
|
26 City Hall Mall, Medford, MA 02155-4754 | |
| (617) 657-6444 | |
| (781) 306-5227 |
| Full Name | Yoon K Cho |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 12 Years |
| Location | 26 City Hall Mall, Medford, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861880395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 277522 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
| Burlington Ob-gyn Assoc Inc | 4082716121 | 3 |
News Archive
The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.
Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) – a highly aggressive and therapy resistant brain tumor that mostly occurs in infants.
Taking postmenopausal hormone replacement therapy increases the risk for ulcerative colitis, but not Crohn's disease, a study shows.
For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.
› Verified 4 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.
Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) – a highly aggressive and therapy resistant brain tumor that mostly occurs in infants.
Taking postmenopausal hormone replacement therapy increases the risk for ulcerative colitis, but not Crohn's disease, a study shows.
For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.
› Verified 4 days ago
| Entity Name | Burlington Ob-gyn Assoc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750343208 PECOS PAC ID: 4082716121 Enrollment ID: O20070221000095 |
News Archive
The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.
Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) – a highly aggressive and therapy resistant brain tumor that mostly occurs in infants.
Taking postmenopausal hormone replacement therapy increases the risk for ulcerative colitis, but not Crohn's disease, a study shows.
For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yoon K Cho, MD 26 City Hall Mall, Medford, MA 02155-4754 Ph: (617) 657-6444 | Yoon K Cho, MD 26 City Hall Mall, Medford, MA 02155-4754 Ph: (617) 657-6444 |
News Archive
The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.
Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) – a highly aggressive and therapy resistant brain tumor that mostly occurs in infants.
Taking postmenopausal hormone replacement therapy increases the risk for ulcerative colitis, but not Crohn's disease, a study shows.
For most American women, their "time of the month" is seen as a hindrance to daily life. In impoverished and developing countries, however, monthly periods are a major cause for concern among women. The lack of affordable, quality sanitary pads results in females missing up to 50 days of school annually - thereby compromising their educational and professional potential.
› Verified 4 days ago
Dr. Beverly Jean Loudin, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5304 | |
Stephanie S Bjork, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Suite 217, Medford, MA 02155 Phone: 781-395-6000 Fax: 781-395-4703 | |
Elizabeth Buechler, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5304 Fax: 781-306-5227 | |
Doreen Neptune-hammond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5304 Fax: 781-306-5227 | |
Mrs. Serena Fasano, WHNP, MPH, CLC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13 Bradlee Rd, Medford, MA 02155 Phone: 781-395-1110 | |
Bernadette Chan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 170 Governors Ave, Prompt Care - Lawrence Memorial Hospital, Medford, MA 02155 Phone: 781-306-6103 Fax: 781-306-6206 | |
Dr. Richard Mason Mcneer Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5298 Fax: 781-306-5227 |